![]() |
|
Panagene has developed its proprietary Bts PNA monomers (Bts ; benzothiazole-2-sulfonyl group) and proprietary oligomerization process. This unique structures enable PNA oligomerization to be more effective and convenient. The PNA oligomerization using Bts PNA monomers is composed of repetitive cycles of deprotection, coupling and capping. |
|
![]() |
|
Panagene¡¯s PNA synthesis does not require anhydrous conditions or the pre-activation of monomers prior to the coupling reaction. It does not employ coupling reagents, and the excess monomers used in coupling reaction can be easily recovered and re-used (if needed). | |
![]() |
|
![]() |
|
Under deprotection conditions used for the removal of Bts protecting group, transacylation of PNA is minimized. Side reactions in PNA synthesis path 1 : trans-acylation of the nucleobaseacetyl moiety, path 2 : N-terminal detachment of the monomer. |
|
Panagene¡¯s proprietary method for the PNA synthesis using Bts monomers is superior to the other method that is publicly known with Fmoc monomers. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|